Abstract
Diabetic neuropathy has multiple aspects of pathophysiology including metabolic derangements and alterations of microvessel with hyperglycemia. Currently, there is no effective long-term treatment based on the pathologic mechanisms. Nerve regeneration with nerve growth factor (NGF) has been on clinical trials as a treatment option. This article reviews an action of a herbal medicine, DA 9801, whose mechanism of action is related to NGF in treating diabetic neuropathy.
Similar content being viewed by others
References
Boucher, T. J. and McMahon, S. B., Neurotrophic factors and neuropathic pain. Curr. Opin. Pharmacol., 1, 66–72 (2001).
Boulton, A. J., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., and Ziegler, D., Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care, 28, 956–962 (2005).
Datamonitor. Forecast insight: Neuropathic pain (2009). Datamonitor. Pipeline and commercial insight: Neuropathic pain (2011).
Edwards, J. L., Vincent, A. M., Cheng, H. T., and Feldman, E. L., Diabetic neuropathy: Mechanisms to management. Pharmacol. Ther., 120, 1–34 (2008).
Guastella, V. and Mick, G., Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy. Diabetes Metab., 35, 12–19 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, SZ., Son, MW. Novel botanical drug for the treatment of diabetic neuropathy. Arch. Pharm. Res. 34, 865–867 (2011). https://doi.org/10.1007/s12272-011-0621-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0621-2